Dustin Davis

Dustin’s experience includes advising:

• 1892 Holdings, a consortium led and managed by Amit Bhatia, in the purchase of a strategic minority equity stake in Premier League club Liverpool F.C. from Fenway Sports Group
• Apollo on its US$1.45 billion carve-out acquisition of Molycop, a leading global supplier of grinding media for the mining industry
• The Carlyle Group and its portfolio companies on multiple transactions, including on the:
  • EUR 7.7 billion carve-out acquisition by Carlyle of BASF SE’s automative OEM coatings, automotive refinish coatings and surface treatment businesses
  • US$1.5 billion carve-out acquisition by Carlyle of Worldpac from Advance Auto Parts, Inc. (NYSE: AAP)
  • US$1.3 billion strategic investment by Carlyle in Trucordia, a top 20 US insurance brokerage
  • Strategic investment by Carlyle in Entertainment 360, one of the world’s premier talent management companies
  • Recapitalization of CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans, in connection with Patient Square Capital’s strategic investment in CorroHealth and sharing joint control of CorroHealth with Carlyle
  • Upsized US$1.44 billion IPO of StandardAero (NYSE: SARO)
  • Acquisition of a healthcare automation and patient engagement software company by a portfolio company of Carlyle
  • US$365 million carve-out acquisition by a portfolio company of Carlyle of the medical software technology business of a publicly traded company
• Permira and its portfolio companies on multiple transactions, including on the:
  • Merger of Seismic with Highspot
  • Minority investment by Permira and other sponsors in an enterprise AI services company
  • Strategic investment by Permira in Versaterm, a public safety software technology company
• Sale of an orthopedic technology manufacturer to a global medical device leader
• A private direct-investment partnership on multiple strategic and minority investment transactions
• Medical Faculty Associates (MFA), a nonprofit organization providing clinical services and medical staffing in more than 50 medical and surgical specialties, in connection with various restructuring transactions
• A medical device technology company in its cash and stock acquisition of certain assets of a publicly traded medical company
• Revolution Medicines (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, in its US$1 billion+ all-stock acquisition of EQRx, Inc. (Nasdaq: EQRX)
• A middle market private equity firm focused on infrastructure and services companies in the US$250 million sale of its portfolio company, a water infrastructure technology company, to another leading private equity firm
• Tritium Partners, a private equity firm focused on technology and services companies, on multiple growth equity transactions
• SMART Global Holdings (Nasdaq: SGH) in its acquisition of Stratus Technologies
• BigCommerce (Nasdaq: BIGC) in its acquisition of Bundle B2B
• Multiple investors and companies on various venture capital financing transactions
• Rice Acquisition Corp., a special purpose acquisition vehicle, in its US$1.15 billion business combination with Aria Energy and Archaea Energy to form Archaea Energy (NYSE: LFG), a publicly traded renewable natural gas platform*
• CleanCapital in its US$300 million equity raise for a new solar and storage platform and acquisition of two C&I solar portfolios*
• KKR in its US$1.4 billion joint investment with NextEra Energy Resources (NYSE: NEE) and NextEra Energy Partners (NYSE: NEP) to acquire a portfolio of wind and solar energy assets*
• Charter Communications (Nasdaq: CHTR) in its strategic investment in Comscore (Nasdaq: SCOR)*
• Hilcorp Alaska in its US$5.6 billion acquisition of BP’s (NYSE: BP) upstream and midstream Alaska businesses*
• Schlumberger Limited (NYSE: SLB) in the sale of its North American onshore hydraulic fracturing business to Liberty Energy (NYSE: LBRT)*
• Warburg Pincus in its US$1 billion controlling investment in an exploration and production company*

*Matter handled prior to joining Latham